E. Greselin

463 total citations
29 papers, 383 citations indexed

About

E. Greselin is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, E. Greselin has authored 29 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in E. Greselin's work include Cholesterol and Lipid Metabolism (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). E. Greselin is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). E. Greselin collaborates with scholars based in Canada and United States. E. Greselin's co-authors include D. Dvornik, Mitchell N. Cayen, Eckhardt S. Ferdinandi, N. Simard-Duquesne, J.-E. Dubuc, M. Kraml, William T. Robinson, Claude Viau, Peter Hill and Jules Brodeur and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Endocrinology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E. Greselin

28 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Greselin Canada 11 120 94 79 75 60 29 383
N. Weger Germany 16 158 1.3× 69 0.7× 95 1.2× 108 1.4× 30 0.5× 48 694
Allan B. Graham United Kingdom 14 188 1.6× 50 0.5× 145 1.8× 48 0.6× 47 0.8× 23 469
Carole Evans United States 10 90 0.8× 69 0.7× 127 1.6× 23 0.3× 77 1.3× 13 497
Lawrence M. Zaccaro United States 9 269 2.2× 54 0.6× 51 0.6× 23 0.3× 71 1.2× 12 535
R.M. Noll United States 11 157 1.3× 22 0.2× 85 1.1× 122 1.6× 50 0.8× 13 446
Jerry J. Hjelle United States 19 237 2.0× 39 0.4× 248 3.1× 46 0.6× 63 1.1× 32 764
P. Niebes United States 10 151 1.3× 70 0.7× 45 0.6× 25 0.3× 107 1.8× 24 467
Karmela Schneidman United States 10 134 1.1× 73 0.8× 209 2.6× 29 0.4× 78 1.3× 13 584
Doug Carey Canada 10 244 2.0× 46 0.5× 36 0.5× 38 0.5× 55 0.9× 11 470
Gül Özdemirler Türkiye 13 117 1.0× 26 0.3× 85 1.1× 25 0.3× 91 1.5× 19 493

Countries citing papers authored by E. Greselin

Since Specialization
Citations

This map shows the geographic impact of E. Greselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Greselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Greselin more than expected).

Fields of papers citing papers by E. Greselin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Greselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Greselin. The network helps show where E. Greselin may publish in the future.

Co-authorship network of co-authors of E. Greselin

This figure shows the co-authorship network connecting the top 25 collaborators of E. Greselin. A scholar is included among the top collaborators of E. Greselin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Greselin. E. Greselin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chouinard, Sylvie, Claude Viau, & E. Greselin. (1992). Enzymuria and Tubular Proteinuria in Diabetic Rats: A 12-Week Follow-Up Study. Renal Failure. 14(1). 41–47. 4 indexed citations
2.
Chakrabarti, Saroj, et al.. (1992). Species differences in the nephrotoxic response to S-(1,2-dichlorovinyl)glutathione. Toxicology Letters. 60(3). 343–351. 2 indexed citations
3.
Zaror‐Behrens, Gloria, Rudolf Mueller, E. Greselin, & Willy A. Behrens. (1991). Lack of vitamin E cytoprotective effects on indomethacin-induced gastric lesions.. PubMed. 72(3). 327–35. 7 indexed citations
4.
Charbonneau, Michel, E. Greselin, Jules Brodeur, & Gàbriel L. Plaa. (1991). Influence of acetone on the severity of the liver injury induced by haloalkane mixtures. Canadian Journal of Physiology and Pharmacology. 69(12). 1901–1907. 2 indexed citations
5.
Bouthillier, L. P., E. Greselin, Jules Brodeur, Claude Viau, & Michel Charbonneau. (1991). Male rat specific nephrotoxicity resulting from subchronic administration of hexachlorobenzene. Toxicology and Applied Pharmacology. 110(2). 315–326. 13 indexed citations
6.
Souich, P. du, et al.. (1990). Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites. Canadian Journal of Physiology and Pharmacology. 68(8). 1055–1061. 12 indexed citations
7.
Gérin, Michel, et al.. (1988). Aviation gasoline: comparative subchronic nephrotoxicity study in the male rat. Toxicology Letters. 44(1-2). 13–19. 3 indexed citations
8.
Cayen, Mitchell N., David Hicks, Eckhardt S. Ferdinandi, et al.. (1985). Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.. Drug Metabolism and Disposition. 13(4). 412–419. 14 indexed citations
9.
Simard-Duquesne, N., E. Greselin, J.-E. Dubuc, & D. Dvornik. (1985). The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats. Metabolism. 34(10). 885–892. 46 indexed citations
10.
Simard-Duquesne, N., et al.. (1985). Prevention of Cataract Development in Severely Galactosemic Rats by the Aldose Reductase Inhibitor, Tolrestat. Experimental Biology and Medicine. 178(4). 599–605. 39 indexed citations
11.
Cayen, Mitchell N., et al.. (1982). Effect of AY-25,712 on fatty acid metabolism in rats. Atherosclerosis. 45(3). 281–290. 5 indexed citations
12.
Cayen, Mitchell N., M. Kraml, Eckhardt S. Ferdinandi, E. Greselin, & D. Dvornik. (1981). The Metabolic Disposition of Etodolac in Rats, Dogs, and Man. Drug Metabolism Reviews. 12(2). 339–362. 49 indexed citations
13.
Cayen, Mitchell N., Eckhardt S. Ferdinandi, E. Greselin, & D. Dvornik. (1979). Studies on the disposition of diosgenin in rats, dogs, monkeys and man. Atherosclerosis. 33(1). 71–87. 39 indexed citations
14.
Cayen, Mitchell N., Eckhardt S. Ferdinandi, E. Greselin, William T. Robinson, & D. Dvornik. (1977). Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.. Journal of Pharmacology and Experimental Therapeutics. 200(1). 33–43. 44 indexed citations
15.
Greselin, E., et al.. (1974). Further toxicity studies with antimycin, a fish eradicant. Journal of Agricultural and Food Chemistry. 22(6). 996–998. 3 indexed citations
16.
Greselin, E., et al.. (1967). Toxicology Studies of Antimycin, a Fish Eradicant. Transactions of the American Fisheries Society. 96(3). 320–326. 8 indexed citations
17.
Hill, Peter & E. Greselin. (1967). Lung phospholipids: Biochemical and histologic changes induced by the cholesterol biosynthesis inhibitor AY-9944. Toxicology and Applied Pharmacology. 11(2). 245–256. 7 indexed citations
18.
Marton, A. V., E. Greselin, Morris L. Givner, & Katherine Voith. (1964). Effect of a Novel Hypocholesterolemic Agent,Trans-1,4-bis- (2- chlorobenzylaminomethyl)Cyclohexane Dihydrochloride (AY- 9944) on Adrenal Morphology. Endocrinology. 75(4). 469–476. 9 indexed citations
19.
Greselin, E.. (1962). The Sterilization of the Bull: A Review of the Literature.. PubMed. 26(4). 84–6.
20.
Greselin, E.. (1961). Detection of Otitis Media in the Rat.. PubMed. 25(11). 274–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Weger Breakdown of academic impact, for papers by Allan B. Graham Breakdown of academic impact, for papers by Carole Evans Breakdown of academic impact, for papers by Lawrence M. Zaccaro Breakdown of academic impact, for papers by R.M. Noll Breakdown of academic impact, for papers by Jerry J. Hjelle Breakdown of academic impact, for papers by P. Niebes Breakdown of academic impact, for papers by Karmela Schneidman Breakdown of academic impact, for papers by Doug Carey Breakdown of academic impact, for papers by Gül Özdemirler
Rankless by CCL
2026